PubRank

J McCauley

Author PubWeight™ 109.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Kidney transplantation under FK 506. JAMA 1990 7.45
2 Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc 1990 4.90
3 Kidney transplantation under FK 506 immunosuppression. Transplant Proc 1991 3.31
4 Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol 2001 2.76
5 Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet 1990 2.66
6 FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994 2.50
7 Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 2006 2.48
8 Characterization of influenza virus RNA complete transcripts. Virology 1982 2.31
9 FK 506 in clinical kidney transplantation. Transplant Proc 1991 2.29
10 A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 1995 2.09
11 FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. Lancet 1990 1.94
12 Influenza virus RNA segment 7 has the coding capacity for two polypeptides. Virology 1980 1.80
13 Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc 1993 1.72
14 Nucleotide sequences at the terminal of La Crosse virus RNAs. Nucleic Acids Res 1980 1.61
15 New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 1991 1.56
16 Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 2005 1.56
17 Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci U S A 1999 1.54
18 An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant 2001 1.48
19 Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation 1992 1.45
20 Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome. Br J Obstet Gynaecol 1994 1.43
21 Adverse effects associated with the use of FK 506. Transplant Proc 1991 1.41
22 FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc 1991 1.37
23 BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995 1.28
24 A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. Clin Transplant 1994 1.15
25 A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation 1999 1.14
26 A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc 1995 1.13
27 FK506 in pediatric kidney transplantation--primary and rescue experience. Pediatr Nephrol 1995 1.11
28 Tacrolimus in renal transplantation. Transplant Proc 1996 1.10
29 An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders. J Clin Pharmacol 1993 1.09
30 The spectrum of ciclosporin nephrotoxicity. Am J Nephrol 1990 1.05
31 FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin Immunopathol 1993 1.02
32 Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation 1999 1.00
33 Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. Transplant Proc 1997 0.98
34 Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant 2008 0.98
35 Structure and synthesis of influenza virus complementary RNAs. Philos Trans R Soc Lond B Biol Sci 1980 0.97
36 Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999 0.96
37 Interferon-alpha-induced acute renal allograft rejection. Transplantation 1995 0.95
38 Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation 1997 0.95
39 Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant 2007 0.92
40 Toluidine blue in the corroboration of rape in the adult victim. Am J Emerg Med 1987 0.91
41 Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 1998 0.91
42 Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: does dissynchronous rejection really exist? Transplantation 2000 0.91
43 Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. Clin Transplant 1997 0.90
44 PORCN gene mutations and the protean nature of focal dermal hypoplasia. Br J Dermatol 2009 0.90
45 Toluidine blue in the detection of perineal lacerations in pediatric and adolescent sexual abuse victims. Pediatrics 1986 0.90
46 Methods for the detection of non-random base substitution in virus genes: models of synonymous nucleotide substitution in picornavirus genes. Virus Genes 1998 0.89
47 Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transplant Proc 2005 0.88
48 Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report. Transplant Proc 1991 0.87
49 Relationship of cytoskeletal filaments to annular gap junction expression in human adrenal cortical tumor cells in culture. Exp Cell Res 1997 0.86
50 Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc 2005 0.86
51 Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc 1993 0.85
52 Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol 1994 0.85
53 The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. Clin Transpl 1995 0.85
54 Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity. J Am Soc Nephrol 1995 0.85
55 Centrosome proteins: a major class of autoantigens in scleroderma. J Clin Immunol 1999 0.84
56 Tacrolimus nephrotoxicity after renal transplantation. Transplant Proc 1997 0.83
57 Reducing the length of stay after kidney transplantation--the intensive outpatient unit. Clin Transplant 1998 0.82
58 "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. Transplantation 1996 0.82
59 Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation 1999 0.82
60 Cancer risk with alemtuzumab following kidney transplantation. Clin Transplant 2013 0.81
61 Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc 1998 0.81
62 Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy. Transplant Proc 1991 0.81
63 FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 1991 0.80
64 Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis. Ther Drug Monit 1996 0.80
65 Influenza virus haemagglutinin signal sequence. FEBS Lett 1979 0.80
66 Family awareness demonstrated by family practice residents: physician behavior and patient opinions. J Fam Pract 1985 0.79
67 Vitamin K deficiency with hemorrhage after kidney and combined kidney-pancreas transplantation. Am J Kidney Dis 1999 0.79
68 Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. Transplant Proc 1997 0.79
69 Two-year experience with FK 506 in pediatric patients. Transplant Proc 1993 0.78
70 Functional analysis of hamster kidney xenografts in the rat: possible functional incompatibility and adaptation of hamster kidney grafts in a xenogenic rat environment. Transplant Proc 1996 0.78
71 Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. Transplant Proc 1999 0.78
72 In vitro effects of cyclosporine and FK 506 on the renal cortex. Transplant Proc 1991 0.78
73 Quantitative analysis of 23-valent 'Pneumovax' by automated rate nephelometry. J Biol Stand 1984 0.77
74 The effect of potassium ion depletion on postinfarction canine cardiac arrhythmias. Circulation 1988 0.77
75 FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. Transplant Proc 1993 0.77
76 Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc 2001 0.76
77 Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. Transplant Proc 1995 0.76
78 Percutaneous transluminal renal angioplasty in nonatherosclerotic renovascular hypertension. Long-term results. Hypertension 1985 0.75
79 Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A(H7N9) virus, May 2013. Euro Surveill 2014 0.75
80 Posttransplant hypertension in blacks versus nonblacks. Transplant Proc 1993 0.75
81 Alopecia as a consequence of tacrolimus therapy. Transplantation 1998 0.75
82 A tuberculosis outbreak in a renal transplant program. Transplant Proc 1991 0.75
83 Outcome of kidney transplantation in African-Americans using tacrolimus. Transplant Proc 1997 0.75
84 A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol 1998 0.75
85 A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. Transplant Proc 2002 0.75
86 A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation. Transplant Proc 1991 0.75
87 Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients. Transplant Proc 1995 0.75
88 Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh. Transplant Proc 1993 0.75
89 Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc 1993 0.75
90 Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 2001 0.75
91 Five-year experience with tacrolimus rescue for renal allograft rejection. Transplant Proc 1997 0.75
92 The galilean satellites and jupiter: voyager 2 imaging science results. Science 1979 0.75
93 Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. J Transpl Coord 1999 0.75
94 Assessment of cervical carotid artery disease. A comparison between the Doppler "Echoflow" and conventional angiography. Med J Aust 1985 0.75
95 ESwab challenges influenza virus propagation in cell cultures. Euro Surveill 2014 0.75
96 Oral care for institutionalized geriatric patients. Nurs Homes 1982 0.75
97 Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. Transplant Proc 2000 0.75
98 Inability of effluent hyaluronic acid levels to predict early graft function in clinical renal transplantation. Transplantation 1993 0.75
99 Social supports and stress as predictors of illness. J Fam Pract 1985 0.75
100 A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. Transplant Proc 1999 0.75
101 Significance of polymorphonuclear leukocytes in traumatic lumbar punctures. South Med J 1985 0.75
102 Future directions for the European influenza reference laboratory network in influenza surveillance. Euro Surveill 2015 0.75
103 Bilateral occlusion of the subclavian veins due to chronic indwelling subclavian catheters. Mil Med 1987 0.75
104 Simultaneous pancreas-kidney transplantation at the University of Pittsburgh. Clin Transpl 1999 0.75
105 FK 506 interaction with danazol. Lancet 1993 0.75
106 Superior vena cava syndrome due to subclavian hemodialysis catheters. Mil Med 1990 0.75
107 Computer-guided concentration-controlled trials in autoimmune disorders. Ther Drug Monit 1993 0.75
108 A spectroscopic investigation of losartan polymorphs. Pharm Res 1993 0.75
109 [Clinical experience with FK 506]. Presse Med 1991 0.75
110 Interviewing style and response to family information by family practice residents. Fam Med 1987 0.75